Video Debriefing at the Delivery Ward

Study Overview
=================
Brief Summary
-----------------
Postpartum hemorrhage continues to be the leading cause of maternal morbidity and mortality worldwide. Successful management of postpartum hemorrhage requires not only administration of the right medicine, but also a rapid and coordinated response from a multi-professional team. A prerequisite for this is that the individuals are well trained, which the investigators believe can be improved by video debriefing of real-life events. The purpose of this study is to improve obstetric teams management of postpartum hemorrhage using video recordings of real-life events in post event debriefings. Cameras are placed in the ceiling of all delivery rooms to record obstetric teams' management of postpartum hemorrhage. Video recording requires informed consent from all participants. After an event, the team will review their own performance on video in a debriefing session to improve future performance.

Detailed Description
-----------------
Background: Video review was first introduced in healthcare in the 1980s to improve emergency teams' management of critical situations by having them review their own performance on video in a debriefing session. Video debriefing offers an opportunity to review the care delivered in high-stake, high-risk, and time-critical situations. Video debriefing has been found to improve the performance of neonatal resuscitation teams and trauma teams; however, video debriefing has not generally been accepted in the delivery ward. A recent PhD project developed a method for systematically filming obstetric emergencies, in two Danish hospitals, where informed consent had been obtained from all participants. In addition, the project developed a method for systematically assessing obstetric teams' clinical performance during postpartum hemorrhage The aim of the study is to examine the effect of real-life video debriefing on obstetric teams' management of major postpartum hemorrhage. Material and methods: The study will be conducted at two Danish hospitals, Aarhus University Hospital (5,000 deliveries per year) and Horsens Regional Hospital (2,300 deliveries per year). All delivery rooms have been equipped with an automatic recording system that enables filming of all postpartum hemorrhage. Video recording requires informed consent from all participants. Women expecting to deliver will be invited to provide informed consent for video recording. If a woman declines the invitation, the cameras will be covered up according to our protocol. If video recording occurs, all participants will be asked to give informed consent again. Video debriefing will be conducted by educated facilitators of debriefing. Debriefings will follow a protocol and will focus on teams' clinical performance and non-technical skills. The main focus of the debriefing protocol will be clinical debriefing with a main goal of improving clinical performance and patient care. Videos will be included as follows: 1) Baseline video inclusion, before introducing real-life video debriefings of team performance; 2) During the start-up of the debriefings in an exploratory study; 3) After real-life video debriefings have been introduced as standard procedure. Perspectives: This project is the first to evaluate the implementation, feasibility and use of real-life video debriefing in obstetric care. Results from this project can revolutionize the ability to learn from clinical cases and can guide how video can be introduced in ways acceptable to women, relatives and healthcare providers.

Official Title
-----------------
Video Debriefing at the Delivery Ward - Empowering Obstetric Teams to High Performance

Conditions
-----------------
Postpartum Hemorrhage

Intervention / Treatment
-----------------
* Behavioral: Video debriefing


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Women with major postpartum hemorrhage (1.0 liter or more). Exclusion Criteria: Language difficulties requiring an interpreter or translator
Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Intervention Model: Single Group Assignment
Interventional Model Description: Data - videos of team performance - will be included as follows: Year 1) Baseline. Video inclusion, before introducing real-life video debriefings of team performance (n=200). Year 2) During the start-up of the debriefings (n=20) which will be evaluated in a feasibility study. Year 2-3) Intervention. After real-life video debriefings have been introduced as standard procedure (n=200).
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Intervention - Video debriefing<br>Baseline period (year 1): Standard practice. Intervention period (year 2-3): All teams will be assigned to video debriefing. | Behavioral: Video debriefing<br>* Obstetric teams will review their own performance on video in a debriefing session to improve future performance.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Clinical performance | Videos will be assessed by raters using the TeamOBS-PPH checklist (Brogaard L et al, Development of the TeamOBS-PPH - targeting clinical performance in postpartum hemorrhage, 2018) | All videos will be assessed 2.5 years (autumn 2023) | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Non-technical performance | Videos will be assessed by raters using the AOTP checklist. | All videos will be assessed 2.5 years (autumn 2023) | 
| Maternal birth characteristics. Time of day. | - Day/Night | Data will be assessed 2.5 years (autumn 2023) | 
| Maternal birth characteristics. Blood loss. | - Total blood loss (ml) | Data will be assessed 2.5 years (autumn 2023) | 
| Maternal birth characteristics. GA. | - Gestational age | Data will be assessed 2.5 years (autumn 2023) | 
| Maternal birth characteristics. Birth length (>18 hours). | - Yes/No | Data will be assessed 2.5 years (autumn 2023) | 
| Maternal birth characteristics. Epidural | - Yes/No | Data will be assessed 2.5 years (autumn 2023) | 
| Maternal birth characteristics. Oxytocin. | - Yes/No | Data will be assessed 2.5 years (autumn 2023) | 
| Maternal birth characteristics. Induction. | - Yes/No | Data will be assessed 2.5 years (autumn 2023) | 
| Maternal birth characteristics. Twin pregnancy. | - Yes/No | Data will be assessed 2.5 years (autumn 2023) | 
| Maternal characteristics additional. Age. | - Years | Data will be assessed 2.5 years (autumn 2023) | 
| Maternal characteristics additional. BMI. | - BMI | Data will be assessed 2.5 years (autumn 2023) | 
| Maternal characteristics additional. Previous postpartum hemorrhage. | - Yes/No | Data will be assessed 2.5 years (autumn 2023) | 
| Maternal characteristics additional. Previous births | - Number | Data will be assessed 2.5 years (autumn 2023) | 
| Team characteristics. Team size. | - Number of team members involved | Data will be assessed 2.5 years (autumn 2023) | 
| Team characteristics. Hospital. | - Regional / University | Data will be assessed 2.5 years (autumn 2023) | 
| Neonatal characteristics. Mean birth weight. | - Grams | Data will be assessed 2.5 years (autumn 2023) | 
| Implementation of video debriefing | Number of debriefing sessions performed (in total / per participant / failed attempted sessions). | Data will be assessed 2.5 years (autumn 2023) |